Our previously study revealed that ANXA1 was modified by the small ubiquitin-related modifier (SUMO) protein, a process termed SUMOylation, and this modification was greatly weakened after cerebral ischemia 16. The gene discussed is ANXA1; the disease is Cerebral ischemia.